US Stock MarketDetailed Quotes

Astellas Pharma (ADR) (ALPMY)

Watchlist
  • 15.430
  • -0.050-0.32%
15min DelayClose Apr 24 15:58 ET
27.64BMarket Cap35.39P/E (TTM)

Astellas Pharma (ADR) (ALPMY) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
Total revenue
571.21B
6.91%505.79B
19.25%1.91T
26.17%473.12B
5.60%1.6T
414.6B
4.91%421.93B
3.09%392.15B
-1.78%374.99B
17.16%1.52T
Operating revenue
--571.21B
6.91%505.79B
19.25%1.91T
26.17%473.12B
5.60%1.6T
--414.6B
4.91%421.93B
3.09%392.15B
-1.78%374.99B
17.16%1.52T
Cost of revenue
114.4B
4.05%94.83B
19.39%349.21B
32.18%91.14B
1.43%292.49B
73.23B
1.98%75.9B
18.52%74.41B
-22.42%68.95B
13.97%288.35B
Gross profit
456.81B
7.59%410.97B
19.21%1.56T
24.82%381.99B
6.58%1.31T
341.37B
5.58%346.04B
0.04%317.74B
4.48%306.04B
17.94%1.23T
Operating expense
322.26B
-4.71%318.42B
17.85%1.52T
28.04%334.17B
17.61%1.29T
387.27B
23.00%327.17B
38.16%320.95B
0.27%260.99B
20.45%1.1T
Selling and administrative expenses
--221.78B
-4.78%197B
13.91%843.03B
23.01%206.88B
17.43%740.11B
--193.15B
22.38%199.5B
15.99%179.28B
9.64%168.18B
14.84%630.27B
-General and administrative expense
--221.78B
-4.78%197B
13.91%843.03B
23.01%206.88B
17.43%740.11B
--193.15B
22.38%199.5B
15.99%179.28B
9.64%168.18B
14.84%630.27B
Research and development costs
--75.6B
-17.42%71.7B
11.38%327.65B
34.41%86.82B
6.54%294.19B
--77.85B
11.23%74.39B
18.70%77.36B
-12.72%64.59B
12.24%276.13B
-Depreciation and amortization
--34.73B
-6.36%32.77B
38.40%136.76B
285.88%34.99B
157.10%98.82B
--32.65B
252.34%32.44B
167.43%24.67B
-15.61%9.07B
35.90%38.44B
Other operating expenses
--10.39B
105.54%21.33B
40.49%235.77B
-54.99%10.38B
6.54%167.81B
--83.84B
-16.34%23.41B
1,106.04%42.94B
-40.00%23.06B
51.00%157.52B
Operating profit
134.54B
93.52%92.54B
112.42%40.25B
6.13%47.82B
-85.60%18.95B
-45.9B
-69.45%18.87B
-103.77%-3.22B
38.09%45.06B
0.45%131.56B
Net non-operating interest income expense
-545M
-2,511.73%-4.23B
-1,682.36%-9.8B
-115.34%-162M
17.79%-550M
-62M
-1.23%-1.65B
-94.90%105M
171.89%1.06B
-155.75%-669M
Non-operating interest income
--1.9B
-61.53%1.67B
-31.26%7.87B
14.75%4.33B
41.25%11.46B
--4.12B
0.60%1.18B
-33.41%2.37B
307.34%3.78B
31.89%8.11B
Non-operating interest expense
--2.45B
31.21%5.9B
47.25%17.68B
65.26%4.5B
36.75%12.01B
--4.19B
0.96%2.83B
50.46%2.27B
13.52%2.72B
77.39%8.78B
Other net income (expense)
Special income (charges)
--5M
307.04%3.7B
-89.22%1.05B
1,583.33%909M
4,491.98%9.74B
--0
783.33%318M
468,100.00%9.36B
-68.24%54M
-99.13%212M
-Less:Other special charges
---5M
-307.04%-3.7B
89.22%-1.05B
-1,583.33%-909M
-4,491.98%-9.74B
--0
-783.33%-318M
-468,100.00%-9.36B
68.24%-54M
99.13%-212M
Income before tax
133.96B
79.06%90.42B
25.10%31.24B
7.78%50.5B
-81.14%24.97B
-48.66B
-71.03%17.31B
-94.00%5.33B
47.89%46.85B
-15.63%132.36B
Income tax
33.63B
70.60%21.99B
-346.21%-19.51B
-6.04%12.89B
-76.45%7.92B
-15.38B
-75.34%2.8B
-60.49%6.79B
99.81%13.72B
2.58%33.65B
Net income
100.32B
81.96%68.42B
197.72%50.75B
13.50%37.6B
-82.73%17.05B
-33.28B
-70.02%14.51B
-102.04%-1.46B
33.52%33.13B
-20.45%98.71B
Net income continuous Operations
--100.32B
81.96%68.42B
197.72%50.75B
13.50%37.6B
-82.73%17.05B
---33.28B
-70.02%14.51B
-102.04%-1.46B
33.52%33.13B
-20.45%98.71B
Minority interest income
Net income attributable to the parent company
100.38B
81.96%68.42B
197.72%50.75B
13.50%37.6B
-82.73%17.05B
-33.28B
-70.02%14.51B
-102.04%-1.46B
33.52%33.13B
-20.45%98.71B
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
100.38B
81.96%68.42B
197.72%50.75B
13.50%37.6B
-82.73%17.05B
-33.28B
-70.02%14.51B
-102.04%-1.46B
33.52%33.13B
-20.45%98.71B
Basic earnings per share
56.04
82.00%38.22
198.11%28.35
13.76%21
-82.47%9.51
-18.55
-69.54%8.09
-102.06%-0.81
35.84%18.46
-19.14%54.24
Diluted earnings per share
55.85
82.00%38.11
198.20%28.24
13.68%20.94
-82.49%9.47
-18.55
-69.64%8.06
-102.06%-0.81
35.54%18.42
-19.33%54.09
Dividend per share
0
0
6.47%73.7343
0
14.23%69.2531
33.9272
0
11.04%35.3258
0
25.58%60.6264
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q3)Dec 31, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023
Total revenue 571.21B6.91%505.79B19.25%1.91T26.17%473.12B5.60%1.6T414.6B4.91%421.93B3.09%392.15B-1.78%374.99B17.16%1.52T
Operating revenue --571.21B6.91%505.79B19.25%1.91T26.17%473.12B5.60%1.6T--414.6B4.91%421.93B3.09%392.15B-1.78%374.99B17.16%1.52T
Cost of revenue 114.4B4.05%94.83B19.39%349.21B32.18%91.14B1.43%292.49B73.23B1.98%75.9B18.52%74.41B-22.42%68.95B13.97%288.35B
Gross profit 456.81B7.59%410.97B19.21%1.56T24.82%381.99B6.58%1.31T341.37B5.58%346.04B0.04%317.74B4.48%306.04B17.94%1.23T
Operating expense 322.26B-4.71%318.42B17.85%1.52T28.04%334.17B17.61%1.29T387.27B23.00%327.17B38.16%320.95B0.27%260.99B20.45%1.1T
Selling and administrative expenses --221.78B-4.78%197B13.91%843.03B23.01%206.88B17.43%740.11B--193.15B22.38%199.5B15.99%179.28B9.64%168.18B14.84%630.27B
-General and administrative expense --221.78B-4.78%197B13.91%843.03B23.01%206.88B17.43%740.11B--193.15B22.38%199.5B15.99%179.28B9.64%168.18B14.84%630.27B
Research and development costs --75.6B-17.42%71.7B11.38%327.65B34.41%86.82B6.54%294.19B--77.85B11.23%74.39B18.70%77.36B-12.72%64.59B12.24%276.13B
-Depreciation and amortization --34.73B-6.36%32.77B38.40%136.76B285.88%34.99B157.10%98.82B--32.65B252.34%32.44B167.43%24.67B-15.61%9.07B35.90%38.44B
Other operating expenses --10.39B105.54%21.33B40.49%235.77B-54.99%10.38B6.54%167.81B--83.84B-16.34%23.41B1,106.04%42.94B-40.00%23.06B51.00%157.52B
Operating profit 134.54B93.52%92.54B112.42%40.25B6.13%47.82B-85.60%18.95B-45.9B-69.45%18.87B-103.77%-3.22B38.09%45.06B0.45%131.56B
Net non-operating interest income expense -545M-2,511.73%-4.23B-1,682.36%-9.8B-115.34%-162M17.79%-550M-62M-1.23%-1.65B-94.90%105M171.89%1.06B-155.75%-669M
Non-operating interest income --1.9B-61.53%1.67B-31.26%7.87B14.75%4.33B41.25%11.46B--4.12B0.60%1.18B-33.41%2.37B307.34%3.78B31.89%8.11B
Non-operating interest expense --2.45B31.21%5.9B47.25%17.68B65.26%4.5B36.75%12.01B--4.19B0.96%2.83B50.46%2.27B13.52%2.72B77.39%8.78B
Other net income (expense)
Special income (charges) --5M307.04%3.7B-89.22%1.05B1,583.33%909M4,491.98%9.74B--0783.33%318M468,100.00%9.36B-68.24%54M-99.13%212M
-Less:Other special charges ---5M-307.04%-3.7B89.22%-1.05B-1,583.33%-909M-4,491.98%-9.74B--0-783.33%-318M-468,100.00%-9.36B68.24%-54M99.13%-212M
Income before tax 133.96B79.06%90.42B25.10%31.24B7.78%50.5B-81.14%24.97B-48.66B-71.03%17.31B-94.00%5.33B47.89%46.85B-15.63%132.36B
Income tax 33.63B70.60%21.99B-346.21%-19.51B-6.04%12.89B-76.45%7.92B-15.38B-75.34%2.8B-60.49%6.79B99.81%13.72B2.58%33.65B
Net income 100.32B81.96%68.42B197.72%50.75B13.50%37.6B-82.73%17.05B-33.28B-70.02%14.51B-102.04%-1.46B33.52%33.13B-20.45%98.71B
Net income continuous Operations --100.32B81.96%68.42B197.72%50.75B13.50%37.6B-82.73%17.05B---33.28B-70.02%14.51B-102.04%-1.46B33.52%33.13B-20.45%98.71B
Minority interest income
Net income attributable to the parent company 100.38B81.96%68.42B197.72%50.75B13.50%37.6B-82.73%17.05B-33.28B-70.02%14.51B-102.04%-1.46B33.52%33.13B-20.45%98.71B
Preferred stock dividends
Other preferred stock dividends 0000000000
Net income attributable to common stockholders 100.38B81.96%68.42B197.72%50.75B13.50%37.6B-82.73%17.05B-33.28B-70.02%14.51B-102.04%-1.46B33.52%33.13B-20.45%98.71B
Basic earnings per share 56.0482.00%38.22198.11%28.3513.76%21-82.47%9.51-18.55-69.54%8.09-102.06%-0.8135.84%18.46-19.14%54.24
Diluted earnings per share 55.8582.00%38.11198.20%28.2413.68%20.94-82.49%9.47-18.55-69.64%8.06-102.06%-0.8135.54%18.42-19.33%54.09
Dividend per share 006.47%73.7343014.23%69.253133.9272011.04%35.3258025.58%60.6264
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More